Global OTC Anti-Infective Medications Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 96

Published Date: 28 Oct 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The OTC Anti-Infective Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global OTC Anti-Infective Medications size is estimated to be USD  million in 2026 from USD  million in 2020, with a change  % between 2020 and 2021. The global OTC Anti-Infective Medications market size is expected to grow at a CAGR of  % for the next five years.

Market segmentation
OTC Anti-Infective Medications market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Antifungals
    Antiseptic
    Antiparasitics

Market segment by Application, can be divided into
    Hospital Pharmacies
    Drug Stores
    E-Commerce

Market segment by players, this report covers
    GlaxoSmithKline
    Merck
    Pfizer
    Novartis
    Abbott
    Sanofi
    Bristol-Myers Squibb
    Roche
    NanoViricides
    Novabay Pharmaceuticals
    Optimer Pharmaceuticals
    Basilea Pharmaceutica
    MerLion Pharma

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe OTC Anti-Infective Medications product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of OTC Anti-Infective Medications, with revenue, gross margin and global market share of OTC Anti-Infective Medications from 2019 to 2021.
Chapter 3, the OTC Anti-Infective Medications competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and OTC Anti-Infective Medications market forecast, by regions, type and sales channel, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe OTC Anti-Infective Medications research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of OTC Anti-Infective Medications
    1.2 Classification of OTC Anti-Infective Medications by Type
        1.2.1 Overview: Global OTC Anti-Infective Medications Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global OTC Anti-Infective Medications Revenue Market Share by Type in 2020
        1.2.3 Antifungals
        1.2.4 Antiseptic
        1.2.5 Antiparasitics
    1.3 Global OTC Anti-Infective Medications Market by Sales Channel
        1.3.1 Overview: Global OTC Anti-Infective Medications Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospital Pharmacies
        1.3.3 Drug Stores
        1.3.4 E-Commerce
    1.4 Global OTC Anti-Infective Medications Market Size & Forecast
    1.5 Global OTC Anti-Infective Medications Market Size and Forecast by Region
        1.5.1 Global OTC Anti-Infective Medications Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global OTC Anti-Infective Medications Market Size by Region, (2016-2021)
        1.5.3 North America OTC Anti-Infective Medications Market Size and Prospect (2016-2026)
        1.5.4 Europe OTC Anti-Infective Medications Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific OTC Anti-Infective Medications Market Size and Prospect (2016-2026)
        1.5.6 South America OTC Anti-Infective Medications Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa OTC Anti-Infective Medications Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 OTC Anti-Infective Medications Market Drivers
        1.6.2 OTC Anti-Infective Medications Market Restraints
        1.6.3 OTC Anti-Infective Medications Trends Analysis

2 Company Profiles
    2.1 GlaxoSmithKline
        2.1.1 GlaxoSmithKline Details
        2.1.2 GlaxoSmithKline Major Business
        2.1.3 GlaxoSmithKline OTC Anti-Infective Medications Product and Solutions
        2.1.4 GlaxoSmithKline OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 GlaxoSmithKline Recent Developments and Future Plans
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck OTC Anti-Infective Medications Product and Solutions
        2.2.4 Merck OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Merck Recent Developments and Future Plans
    2.3 Pfizer
        2.3.1 Pfizer Details
        2.3.2 Pfizer Major Business
        2.3.3 Pfizer OTC Anti-Infective Medications Product and Solutions
        2.3.4 Pfizer OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Pfizer Recent Developments and Future Plans
    2.4 Novartis
        2.4.1 Novartis Details
        2.4.2 Novartis Major Business
        2.4.3 Novartis OTC Anti-Infective Medications Product and Solutions
        2.4.4 Novartis OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Novartis Recent Developments and Future Plans
    2.5 Abbott
        2.5.1 Abbott Details
        2.5.2 Abbott Major Business
        2.5.3 Abbott OTC Anti-Infective Medications Product and Solutions
        2.5.4 Abbott OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Abbott Recent Developments and Future Plans
    2.6 Sanofi
        2.6.1 Sanofi Details
        2.6.2 Sanofi Major Business
        2.6.3 Sanofi OTC Anti-Infective Medications Product and Solutions
        2.6.4 Sanofi OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Sanofi Recent Developments and Future Plans
    2.7 Bristol-Myers Squibb
        2.7.1 Bristol-Myers Squibb Details
        2.7.2 Bristol-Myers Squibb Major Business
        2.7.3 Bristol-Myers Squibb OTC Anti-Infective Medications Product and Solutions
        2.7.4 Bristol-Myers Squibb OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.8 Roche
        2.8.1 Roche Details
        2.8.2 Roche Major Business
        2.8.3 Roche OTC Anti-Infective Medications Product and Solutions
        2.8.4 Roche OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Roche Recent Developments and Future Plans
    2.9 NanoViricides
        2.9.1 NanoViricides Details
        2.9.2 NanoViricides Major Business
        2.9.3 NanoViricides OTC Anti-Infective Medications Product and Solutions
        2.9.4 NanoViricides OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 NanoViricides Recent Developments and Future Plans
    2.10 Novabay Pharmaceuticals
        2.10.1 Novabay Pharmaceuticals Details
        2.10.2 Novabay Pharmaceuticals Major Business
        2.10.3 Novabay Pharmaceuticals OTC Anti-Infective Medications Product and Solutions
        2.10.4 Novabay Pharmaceuticals OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Novabay Pharmaceuticals Recent Developments and Future Plans
    2.11 Optimer Pharmaceuticals
        2.11.1 Optimer Pharmaceuticals Details
        2.11.2 Optimer Pharmaceuticals Major Business
        2.11.3 Optimer Pharmaceuticals OTC Anti-Infective Medications Product and Solutions
        2.11.4 Optimer Pharmaceuticals OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Optimer Pharmaceuticals Recent Developments and Future Plans
    2.12 Basilea Pharmaceutica
        2.12.1 Basilea Pharmaceutica Details
        2.12.2 Basilea Pharmaceutica Major Business
        2.12.3 Basilea Pharmaceutica OTC Anti-Infective Medications Product and Solutions
        2.12.4 Basilea Pharmaceutica OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Basilea Pharmaceutica Recent Developments and Future Plans
    2.13 MerLion Pharma
        2.13.1 MerLion Pharma Details
        2.13.2 MerLion Pharma Major Business
        2.13.3 MerLion Pharma OTC Anti-Infective Medications Product and Solutions
        2.13.4 MerLion Pharma OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 MerLion Pharma Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global OTC Anti-Infective Medications Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 OTC Anti-Infective Medications Players Market Share
        3.2.2 Top 10 OTC Anti-Infective Medications Players Market Share
        3.2.3 Market Competition Trend
    3.3 OTC Anti-Infective Medications Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global OTC Anti-Infective Medications Revenue and Market Share by Type (2016-2021)
    4.2 Global OTC Anti-Infective Medications Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global OTC Anti-Infective Medications Revenue Market Share by Application (2016-2021)
    5.2 OTC Anti-Infective Medications Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America OTC Anti-Infective Medications Revenue by Type (2016-2026)
    6.2 North America OTC Anti-Infective Medications Revenue by Application (2016-2026)
    6.3 North America OTC Anti-Infective Medications Market Size by Country
        6.3.1 North America OTC Anti-Infective Medications Revenue by Country (2016-2026)
        6.3.2 United States OTC Anti-Infective Medications Market Size and Forecast (2016-2026)
        6.3.3 Canada OTC Anti-Infective Medications Market Size and Forecast (2016-2026)
        6.3.4 Mexico OTC Anti-Infective Medications Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe OTC Anti-Infective Medications Revenue by Type (2016-2026)
    7.2 Europe OTC Anti-Infective Medications Revenue by Application (2016-2026)
    7.3 Europe OTC Anti-Infective Medications Market Size by Country
        7.3.1 Europe OTC Anti-Infective Medications Revenue by Country (2016-2026)
        7.3.2 Germany OTC Anti-Infective Medications Market Size and Forecast (2016-2026)
        7.3.3 France OTC Anti-Infective Medications Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom OTC Anti-Infective Medications Market Size and Forecast (2016-2026)
        7.3.5 Russia OTC Anti-Infective Medications Market Size and Forecast (2016-2026)
        7.3.6 Italy OTC Anti-Infective Medications Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific OTC Anti-Infective Medications Revenue by Type (2016-2026)
    8.2 Asia-Pacific OTC Anti-Infective Medications Revenue by Application (2016-2026)
    8.3 Asia-Pacific OTC Anti-Infective Medications Market Size by Region
        8.3.1 Asia-Pacific OTC Anti-Infective Medications Revenue by Region (2016-2026)
        8.3.2 China OTC Anti-Infective Medications Market Size and Forecast (2016-2026)
        8.3.3 Japan OTC Anti-Infective Medications Market Size and Forecast (2016-2026)
        8.3.4 South Korea OTC Anti-Infective Medications Market Size and Forecast (2016-2026)
        8.3.5 India OTC Anti-Infective Medications Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia OTC Anti-Infective Medications Market Size and Forecast (2016-2026)
        8.3.7 Australia OTC Anti-Infective Medications Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America OTC Anti-Infective Medications Revenue by Type (2016-2026)
    9.2 South America OTC Anti-Infective Medications Revenue by Application (2016-2026)
    9.3 South America OTC Anti-Infective Medications Market Size by Country
        9.3.1 South America OTC Anti-Infective Medications Revenue by Country (2016-2026)
        9.3.2 Brazil OTC Anti-Infective Medications Market Size and Forecast (2016-2026)
        9.3.3 Argentina OTC Anti-Infective Medications Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa OTC Anti-Infective Medications Revenue by Type (2016-2026)
    10.2 Middle East & Africa OTC Anti-Infective Medications Revenue by Application (2016-2026)
    10.3 Middle East & Africa OTC Anti-Infective Medications Market Size by Country
        10.3.1 Middle East & Africa OTC Anti-Infective Medications Revenue by Country (2016-2026)
        10.3.2 Turkey OTC Anti-Infective Medications Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia OTC Anti-Infective Medications Market Size and Forecast (2016-2026)
        10.3.4 UAE OTC Anti-Infective Medications Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global OTC Anti-Infective Medications Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global OTC Anti-Infective Medications Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market OTC Anti-Infective Medications Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global OTC Anti-Infective Medications Revenue (USD Million) by Region (2016-2021)
    Table 5. Global OTC Anti-Infective Medications Revenue Market Share by Region (2021-2026)
    Table 6. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
    Table 7. GlaxoSmithKline Major Business
    Table 8. GlaxoSmithKline OTC Anti-Infective Medications Product and Solutions
    Table 9. GlaxoSmithKline OTC Anti-Infective Medications Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Merck Corporate Information, Head Office, and Major Competitors
    Table 11. Merck Major Business
    Table 12. Merck OTC Anti-Infective Medications Product and Solutions
    Table 13. Merck OTC Anti-Infective Medications Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Pfizer Corporate Information, Head Office, and Major Competitors
    Table 15. Pfizer Major Business
    Table 16. Pfizer OTC Anti-Infective Medications Product and Solutions
    Table 17. Pfizer OTC Anti-Infective Medications Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Novartis Corporate Information, Head Office, and Major Competitors
    Table 19. Novartis Major Business
    Table 20. Novartis OTC Anti-Infective Medications Product and Solutions
    Table 21. Novartis OTC Anti-Infective Medications Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Abbott Corporate Information, Head Office, and Major Competitors
    Table 23. Abbott Major Business
    Table 24. Abbott OTC Anti-Infective Medications Product and Solutions
    Table 25. Abbott OTC Anti-Infective Medications Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Sanofi Corporate Information, Head Office, and Major Competitors
    Table 27. Sanofi Major Business
    Table 28. Sanofi OTC Anti-Infective Medications Product and Solutions
    Table 29. Sanofi OTC Anti-Infective Medications Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
    Table 31. Bristol-Myers Squibb Major Business
    Table 32. Bristol-Myers Squibb OTC Anti-Infective Medications Product and Solutions
    Table 33. Bristol-Myers Squibb OTC Anti-Infective Medications Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Roche Corporate Information, Head Office, and Major Competitors
    Table 35. Roche Major Business
    Table 36. Roche OTC Anti-Infective Medications Product and Solutions
    Table 37. Roche OTC Anti-Infective Medications Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. NanoViricides Corporate Information, Head Office, and Major Competitors
    Table 39. NanoViricides Major Business
    Table 40. NanoViricides OTC Anti-Infective Medications Product and Solutions
    Table 41. NanoViricides OTC Anti-Infective Medications Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Novabay Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 43. Novabay Pharmaceuticals Major Business
    Table 44. Novabay Pharmaceuticals OTC Anti-Infective Medications Product and Solutions
    Table 45. Novabay Pharmaceuticals OTC Anti-Infective Medications Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Optimer Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 47. Optimer Pharmaceuticals Major Business
    Table 48. Optimer Pharmaceuticals OTC Anti-Infective Medications Product and Solutions
    Table 49. Optimer Pharmaceuticals OTC Anti-Infective Medications Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. Basilea Pharmaceutica Corporate Information, Head Office, and Major Competitors
    Table 51. Basilea Pharmaceutica Major Business
    Table 52. Basilea Pharmaceutica OTC Anti-Infective Medications Product and Solutions
    Table 53. Basilea Pharmaceutica OTC Anti-Infective Medications Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. MerLion Pharma Corporate Information, Head Office, and Major Competitors
    Table 55. MerLion Pharma Major Business
    Table 56. MerLion Pharma OTC Anti-Infective Medications Product and Solutions
    Table 57. MerLion Pharma OTC Anti-Infective Medications Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Global OTC Anti-Infective Medications Revenue (USD Million) by Players (2019-2021)
    Table 59. Global OTC Anti-Infective Medications Revenue Share by Players (2019-2021)
    Table 60. Breakdown of OTC Anti-Infective Medications by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 61. OTC Anti-Infective Medications Players Head Office, Products and Services Provided
    Table 62. OTC Anti-Infective Medications Mergers & Acquisitions in the Past Five Years
    Table 63. OTC Anti-Infective Medications New Entrants and Expansion Plans
    Table 64. Global OTC Anti-Infective Medications Revenue (USD Million) by Type (2016-2021)
    Table 65. Global OTC Anti-Infective Medications Revenue Share by Type (2016-2021)
    Table 66. Global OTC Anti-Infective Medications Revenue Forecast by Type (2021-2026)
    Table 67. Global OTC Anti-Infective Medications Revenue by Application (2016-2021)
    Table 68. Global OTC Anti-Infective Medications Revenue Forecast by Application (2021-2026)
    Table 69. North America OTC Anti-Infective Medications Revenue by Type (2016-2021) & (USD Million)
    Table 70. North America OTC Anti-Infective Medications Revenue by Type (2021-2026) & (USD Million)
    Table 71. North America OTC Anti-Infective Medications Revenue by Application (2016-2021) & (USD Million)
    Table 72. North America OTC Anti-Infective Medications Revenue by Application (2021-2026) & (USD Million)
    Table 73. North America OTC Anti-Infective Medications Revenue by Country (2016-2021) & (USD Million)
    Table 74. North America OTC Anti-Infective Medications Revenue by Country (2021-2026) & (USD Million)
    Table 75. Europe OTC Anti-Infective Medications Revenue by Type (2016-2021) & (USD Million)
    Table 76. Europe OTC Anti-Infective Medications Revenue by Type (2021-2026) & (USD Million)
    Table 77. Europe OTC Anti-Infective Medications Revenue by Application (2016-2021) & (USD Million)
    Table 78. Europe OTC Anti-Infective Medications Revenue by Application (2021-2026) & (USD Million)
    Table 79. Europe OTC Anti-Infective Medications Revenue by Country (2016-2021) & (USD Million)
    Table 80. Europe OTC Anti-Infective Medications Revenue by Country (2021-2026) & (USD Million)
    Table 81. Asia-Pacific OTC Anti-Infective Medications Revenue by Type (2016-2021) & (USD Million)
    Table 82. Asia-Pacific OTC Anti-Infective Medications Revenue by Type (2021-2026) & (USD Million)
    Table 83. Asia-Pacific OTC Anti-Infective Medications Revenue by Application (2016-2021) & (USD Million)
    Table 84. Asia-Pacific OTC Anti-Infective Medications Revenue by Application (2021-2026) & (USD Million)
    Table 85. Asia-Pacific OTC Anti-Infective Medications Revenue by Region (2016-2021) & (USD Million)
    Table 86. Asia-Pacific OTC Anti-Infective Medications Revenue by Region (2021-2026) & (USD Million)
    Table 87. South America OTC Anti-Infective Medications Revenue by Type (2016-2021) & (USD Million)
    Table 88. South America OTC Anti-Infective Medications Revenue by Type (2021-2026) & (USD Million)
    Table 89. South America OTC Anti-Infective Medications Revenue by Application (2016-2021) & (USD Million)
    Table 90. South America OTC Anti-Infective Medications Revenue by Application (2021-2026) & (USD Million)
    Table 91. South America OTC Anti-Infective Medications Revenue by Country (2016-2021) & (USD Million)
    Table 92. South America OTC Anti-Infective Medications Revenue by Country (2021-2026) & (USD Million)
    Table 93. Middle East & Africa OTC Anti-Infective Medications Revenue by Type (2016-2021) & (USD Million)
    Table 94. Middle East & Africa OTC Anti-Infective Medications Revenue by Type (2021-2026) & (USD Million)
    Table 95. Middle East & Africa OTC Anti-Infective Medications Revenue by Application (2016-2021) & (USD Million)
    Table 96. Middle East & Africa OTC Anti-Infective Medications Revenue by Application (2021-2026) & (USD Million)
    Table 97. Middle East & Africa OTC Anti-Infective Medications Revenue by Country (2016-2021) & (USD Million)
    Table 98. Middle East & Africa OTC Anti-Infective Medications Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. OTC Anti-Infective Medications Picture
    Figure 2. Global OTC Anti-Infective Medications Revenue Market Share by Type in 2020
    Figure 3. Antifungals
    Figure 4. Antiseptic
    Figure 5. Antiparasitics
    Figure 6. OTC Anti-Infective Medications Revenue Market Share by Sales Channel in 2020
    Figure 7. Hospital Pharmacies Picture
    Figure 8. Drug Stores Picture
    Figure 9. E-Commerce Picture
    Figure 10. Global OTC Anti-Infective Medications Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 11. Global OTC Anti-Infective Medications Revenue and Forecast (2016-2026) & (USD Million)
    Figure 12. Global OTC Anti-Infective Medications Revenue Market Share by Region (2016-2026)
    Figure 13. Global OTC Anti-Infective Medications Revenue Market Share by Region in 2020
    Figure 14. North America OTC Anti-Infective Medications Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. Europe OTC Anti-Infective Medications Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. Asia-Pacific OTC Anti-Infective Medications Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. South America OTC Anti-Infective Medications Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Middle East and Africa OTC Anti-Infective Medications Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. OTC Anti-Infective Medications Market Drivers
    Figure 20. OTC Anti-Infective Medications Market Restraints
    Figure 21. OTC Anti-Infective Medications Market Trends
    Figure 22. GlaxoSmithKline Recent Developments and Future Plans
    Figure 23. Merck Recent Developments and Future Plans
    Figure 24. Pfizer Recent Developments and Future Plans
    Figure 25. Novartis Recent Developments and Future Plans
    Figure 26. Abbott Recent Developments and Future Plans
    Figure 27. Sanofi Recent Developments and Future Plans
    Figure 28. Bristol-Myers Squibb Recent Developments and Future Plans
    Figure 29. Roche Recent Developments and Future Plans
    Figure 30. NanoViricides Recent Developments and Future Plans
    Figure 31. Novabay Pharmaceuticals Recent Developments and Future Plans
    Figure 32. Optimer Pharmaceuticals Recent Developments and Future Plans
    Figure 33. Basilea Pharmaceutica Recent Developments and Future Plans
    Figure 34. MerLion Pharma Recent Developments and Future Plans
    Figure 35. Global OTC Anti-Infective Medications Revenue Share by Players in 2020
    Figure 36. OTC Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 37. Global Top 3 Players OTC Anti-Infective Medications Revenue Market Share in 2020
    Figure 38. Global Top 10 Players OTC Anti-Infective Medications Revenue Market Share in 2020
    Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 40. Global OTC Anti-Infective Medications Revenue Share by Type in 2020
    Figure 41. Global OTC Anti-Infective Medications Market Share Forecast by Type (2021-2026)
    Figure 42. Global OTC Anti-Infective Medications Revenue Share by Application in 2020
    Figure 43. Global OTC Anti-Infective Medications Market Share Forecast by Application (2021-2026)
    Figure 44. North America OTC Anti-Infective Medications Sales Market Share by Type (2016-2026)
    Figure 45. North America OTC Anti-Infective Medications Sales Market Share by Application (2016-2026)
    Figure 46. North America OTC Anti-Infective Medications Revenue Market Share by Country (2016-2026)
    Figure 47. United States OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. Canada OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. Mexico OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Europe OTC Anti-Infective Medications Sales Market Share by Type (2016-2026)
    Figure 51. Europe OTC Anti-Infective Medications Sales Market Share by Application (2016-2026)
    Figure 52. Europe OTC Anti-Infective Medications Revenue Market Share by Country (2016-2026)
    Figure 53. Germany OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. France OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. United Kingdom OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Russia OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Italy OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Asia-Pacific OTC Anti-Infective Medications Sales Market Share by Type (2016-2026)
    Figure 59. Asia-Pacific OTC Anti-Infective Medications Sales Market Share by Application (2016-2026)
    Figure 60. Asia-Pacific OTC Anti-Infective Medications Revenue Market Share by Region (2016-2026)
    Figure 61. China OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Japan OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. South Korea OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. India OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Southeast Asia OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Australia OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. South America OTC Anti-Infective Medications Sales Market Share by Type (2016-2026)
    Figure 68. South America OTC Anti-Infective Medications Sales Market Share by Application (2016-2026)
    Figure 69. South America OTC Anti-Infective Medications Revenue Market Share by Country (2016-2026)
    Figure 70. Brazil OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. Argentina OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Middle East and Africa OTC Anti-Infective Medications Sales Market Share by Type (2016-2026)
    Figure 73. Middle East and Africa OTC Anti-Infective Medications Sales Market Share by Application (2016-2026)
    Figure 74. Middle East and Africa OTC Anti-Infective Medications Revenue Market Share by Country (2016-2026)
    Figure 75. Turkey OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Saudi Arabia OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. UAE OTC Anti-Infective Medications Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Methodology
    Figure 79. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GlaxoSmithKline
Merck
Pfizer
Novartis
Abbott
Sanofi
Bristol-Myers Squibb
Roche
NanoViricides
Novabay Pharmaceuticals
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma

Related Reports

Global OTC Anti-Infective Medications Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global OTC Anti-Infective Medications Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 17 Jan 2022

date Pharma & Healthcare

The OTC Anti-Infective Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Product Tags

otc anti infective medications

OTC Anti-Infective Medications

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>